Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy

Duncan B. Johnstone, Jidong Zhang, Britta George, Catherine Léon, Christian Gachet, Hetty Wong, Rulan Parekh, Lawrence B. Holzman

Research output: Contribution to journalArticle

Abstract

Genome-wide association studies linked single-nucleotide polymorphisms (SNPs) at the MYH9 locus to chronic kidney disease among African-Americans, particularly glomerular diseases such as HIV nephropathy and idiopathic focal and segmental glomerulosclerosis (FSGS). However, these MYH9 SNPs are intronic, and despite extensive sequencing, a causal variant remains elusive. To investigate the role of MYH9 in kidney disease, we selectively deleted Myh9 from mouse podocytes and found that mutant C57BL/6 mice did not develop renal insufficiency or proteinuria compared to control littermates, even when the mice were aged for 9 months. To explain the surprisingly normal phenotype, we considered genetic redundancy with the paralog Myh10 in podocytes, but we found that Myh10 was not expressed in podocytes in Myh9-deficient or control mice. We tested whether Myh9 podocyte deletion predisposed mice to glomerulopathy in response to injury by doxorubicin hydrochloride (Adriamycin), and we found that Myh9 podocyte-deleted mice developed proteinuria and glomerulosclerosis, while control mice were resistant. In summary, Myh9 podocyte deletion in C57BL/6 mice results in susceptibility to experimental doxorubicin hydrochloride glomerulopathy. We review evidence that MYH9 dysfunction in humans results in similar susceptibility and place our data, the first examination of Myh9 kidney disease in experimental animals, in the context of recent findings in human kidney disease, including the role of APOL1.

Original languageEnglish (US)
Pages (from-to)2162-2170
Number of pages9
JournalMolecular and Cellular Biology
Volume31
Issue number10
DOIs
StatePublished - May 2011
Externally publishedYes

Fingerprint

Podocytes
Myosin Heavy Chains
Kidney Diseases
Doxorubicin
Inbred C57BL Mouse
Proteinuria
Single Nucleotide Polymorphism
Focal Segmental Glomerulosclerosis
Genome-Wide Association Study
Chronic Renal Insufficiency
African Americans
Renal Insufficiency
HIV
Phenotype
Wounds and Injuries

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Johnstone, D. B., Zhang, J., George, B., Léon, C., Gachet, C., Wong, H., ... Holzman, L. B. (2011). Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. Molecular and Cellular Biology, 31(10), 2162-2170. https://doi.org/10.1128/MCB.05234-11

Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. / Johnstone, Duncan B.; Zhang, Jidong; George, Britta; Léon, Catherine; Gachet, Christian; Wong, Hetty; Parekh, Rulan; Holzman, Lawrence B.

In: Molecular and Cellular Biology, Vol. 31, No. 10, 05.2011, p. 2162-2170.

Research output: Contribution to journalArticle

Johnstone, DB, Zhang, J, George, B, Léon, C, Gachet, C, Wong, H, Parekh, R & Holzman, LB 2011, 'Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy', Molecular and Cellular Biology, vol. 31, no. 10, pp. 2162-2170. https://doi.org/10.1128/MCB.05234-11
Johnstone, Duncan B. ; Zhang, Jidong ; George, Britta ; Léon, Catherine ; Gachet, Christian ; Wong, Hetty ; Parekh, Rulan ; Holzman, Lawrence B. / Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. In: Molecular and Cellular Biology. 2011 ; Vol. 31, No. 10. pp. 2162-2170.
@article{8edfd3c41db940e886c47b024f20f34a,
title = "Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy",
abstract = "Genome-wide association studies linked single-nucleotide polymorphisms (SNPs) at the MYH9 locus to chronic kidney disease among African-Americans, particularly glomerular diseases such as HIV nephropathy and idiopathic focal and segmental glomerulosclerosis (FSGS). However, these MYH9 SNPs are intronic, and despite extensive sequencing, a causal variant remains elusive. To investigate the role of MYH9 in kidney disease, we selectively deleted Myh9 from mouse podocytes and found that mutant C57BL/6 mice did not develop renal insufficiency or proteinuria compared to control littermates, even when the mice were aged for 9 months. To explain the surprisingly normal phenotype, we considered genetic redundancy with the paralog Myh10 in podocytes, but we found that Myh10 was not expressed in podocytes in Myh9-deficient or control mice. We tested whether Myh9 podocyte deletion predisposed mice to glomerulopathy in response to injury by doxorubicin hydrochloride (Adriamycin), and we found that Myh9 podocyte-deleted mice developed proteinuria and glomerulosclerosis, while control mice were resistant. In summary, Myh9 podocyte deletion in C57BL/6 mice results in susceptibility to experimental doxorubicin hydrochloride glomerulopathy. We review evidence that MYH9 dysfunction in humans results in similar susceptibility and place our data, the first examination of Myh9 kidney disease in experimental animals, in the context of recent findings in human kidney disease, including the role of APOL1.",
author = "Johnstone, {Duncan B.} and Jidong Zhang and Britta George and Catherine L{\'e}on and Christian Gachet and Hetty Wong and Rulan Parekh and Holzman, {Lawrence B.}",
year = "2011",
month = "5",
doi = "10.1128/MCB.05234-11",
language = "English (US)",
volume = "31",
pages = "2162--2170",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy

AU - Johnstone, Duncan B.

AU - Zhang, Jidong

AU - George, Britta

AU - Léon, Catherine

AU - Gachet, Christian

AU - Wong, Hetty

AU - Parekh, Rulan

AU - Holzman, Lawrence B.

PY - 2011/5

Y1 - 2011/5

N2 - Genome-wide association studies linked single-nucleotide polymorphisms (SNPs) at the MYH9 locus to chronic kidney disease among African-Americans, particularly glomerular diseases such as HIV nephropathy and idiopathic focal and segmental glomerulosclerosis (FSGS). However, these MYH9 SNPs are intronic, and despite extensive sequencing, a causal variant remains elusive. To investigate the role of MYH9 in kidney disease, we selectively deleted Myh9 from mouse podocytes and found that mutant C57BL/6 mice did not develop renal insufficiency or proteinuria compared to control littermates, even when the mice were aged for 9 months. To explain the surprisingly normal phenotype, we considered genetic redundancy with the paralog Myh10 in podocytes, but we found that Myh10 was not expressed in podocytes in Myh9-deficient or control mice. We tested whether Myh9 podocyte deletion predisposed mice to glomerulopathy in response to injury by doxorubicin hydrochloride (Adriamycin), and we found that Myh9 podocyte-deleted mice developed proteinuria and glomerulosclerosis, while control mice were resistant. In summary, Myh9 podocyte deletion in C57BL/6 mice results in susceptibility to experimental doxorubicin hydrochloride glomerulopathy. We review evidence that MYH9 dysfunction in humans results in similar susceptibility and place our data, the first examination of Myh9 kidney disease in experimental animals, in the context of recent findings in human kidney disease, including the role of APOL1.

AB - Genome-wide association studies linked single-nucleotide polymorphisms (SNPs) at the MYH9 locus to chronic kidney disease among African-Americans, particularly glomerular diseases such as HIV nephropathy and idiopathic focal and segmental glomerulosclerosis (FSGS). However, these MYH9 SNPs are intronic, and despite extensive sequencing, a causal variant remains elusive. To investigate the role of MYH9 in kidney disease, we selectively deleted Myh9 from mouse podocytes and found that mutant C57BL/6 mice did not develop renal insufficiency or proteinuria compared to control littermates, even when the mice were aged for 9 months. To explain the surprisingly normal phenotype, we considered genetic redundancy with the paralog Myh10 in podocytes, but we found that Myh10 was not expressed in podocytes in Myh9-deficient or control mice. We tested whether Myh9 podocyte deletion predisposed mice to glomerulopathy in response to injury by doxorubicin hydrochloride (Adriamycin), and we found that Myh9 podocyte-deleted mice developed proteinuria and glomerulosclerosis, while control mice were resistant. In summary, Myh9 podocyte deletion in C57BL/6 mice results in susceptibility to experimental doxorubicin hydrochloride glomerulopathy. We review evidence that MYH9 dysfunction in humans results in similar susceptibility and place our data, the first examination of Myh9 kidney disease in experimental animals, in the context of recent findings in human kidney disease, including the role of APOL1.

UR - http://www.scopus.com/inward/record.url?scp=79956071512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956071512&partnerID=8YFLogxK

U2 - 10.1128/MCB.05234-11

DO - 10.1128/MCB.05234-11

M3 - Article

VL - 31

SP - 2162

EP - 2170

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 10

ER -